As 2020 draws to a close, we are all too aware that many in our network have been on the front line of the response to COVID-19 and are still responding to this global public health crisis. We understand that many may not have been able to keep up-to-date with the most recent publications relating to hepatitis C and prisons. As such, we have put together a list of the most relevant publications in the 2019-20 year, and indicated those we would like to highlight as of particular interest.
View the chosen articles below, or download an excel spreadsheet here.
Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, Winter R, Scott N, Howell J, Doyle J, Pedrana A, Lloyd A, Stoove M, Hellard M, Iser D, Thompson A.
Summary: DAAs were delivered effectively and in high numbers in 14 adult prisons in Victoria, Australia using a nurse-led model of care, suggesting that decentralized HCV care could be considered for prison settings.
Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP.
Summary: Although expensive, adopting universal HCV testing and treatment in US prisons is cost-effective.
Mohamed Z, Al-Kurdi D, Nelson M, Shimakawa Y, Selvapatt N, Lacey J, Thursz MR, Lemoine M, Brown AS.
Summary: A higher proportion of English remand inmates were screened and treated within a shorter time period with a simplified test (Oraquick salivary) and treat strategy compared to standard of care (opt-out dried blood spot testing), underscoring that scaling up DBS screening and treatment in England may be sub-optimal for HCV elimination.